The present invention relates to new compounds of formula I, ##STR00001## wherein P, Q, X.sup.1, X.sup.2, X.sup.3, X.sup.4, X.sup.5, R, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, G, M.sup.1, M.sup.2, M.sup.3, m and n, are defined as in formula I, a process for their preparation and new intermediates prepared therein, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.
The present invention relates to new compounds of formula I, ##STR00001## wherein P, Q, X.sup.1, X.sup.2, X.sup.3, X.sup.4, X.sup.5, R, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, G, M.sup.1, M.sup.2, M.sup.3, m and n, are defined as in formula I, a process for their preparation and new intermediates prepared therein, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.
The present invention relates to compounds of Formula 1: 1 and salts solvates and hydrates thereof. The invention further relates to pharmaceutical compositions containing said compounds and methods of treating neurological and neuropsychistric disorders using said compounds.
The present invention relates to compounds of Formula 1, 1 and salts solvates and hydrates thereof. The invention further relates to pharmaceutical compositions containing said compounds and methods of treating neurological, neuropsychiatric, and gastrointestinal disorders using said compounds.
The present invention relates to new compounds of formula I, 1 wherein P, Q, X.sup.1, X.sup.2, X.sup.3, X.sup.4, X.sup.4, R, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, m, n, o, p and q are defined as in any one of claims 1 to 12, a process for their preparation and new intermediates prepared therein, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.